Related Experiment Video
Updated: Feb 15, 2026

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
Avian Retrovirus-Mediated Tumor-Specific Gene Knockout
Wei Wang1, Bingning Dong1, Feng Yang1
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Abstract:
The RCAS (replication-competent avian sarcoma leukosis virus long-terminal repeat with splice acceptor)-TVA (tumor virus A) gene delivery system has been successfully used in modeling human cancers. Based on this, we have recently developed a novel RCI-Oncogene (RCAS-Cre-IRES-Oncogene) gene delivery system that can be used to efficiently manipulate gene expression in spontaneous tumors in vivo. We used this system for tumor gene knockout (TuKO) and demonstrated a crucial role of FGFR1 in driving mammary tumor metastasis. This versatile tumor gene modification system can also be adapted into different configurations to address different questions in appropriate mutant mouse hosts. Here we describe a protocol using the TuKO approach to knock out a gene of interest in tumors in appropriate hosts. © 2018 by John Wiley & Sons, Inc.
Insights
We developed a novel gene delivery system, RCAS-Cre-IRES-Oncogene (RCI-Oncogene), for in vivo tumor gene knockout. This system demonstrated FGFR1
Area of Science:
- Oncology
- Gene Therapy
- Cancer Research
Background:
- The replication-competent avian sarcoma leukosis virus long-terminal repeat with splice acceptor-tumor virus A (RCAS-TVA) system is established for cancer modeling.
- Spontaneous tumor gene manipulation in vivo requires efficient and versatile gene delivery methods.
Purpose of the Study:
- To introduce a novel gene delivery system, RCAS-Cre-IRES-Oncogene (RCI-Oncogene), for precise gene manipulation in spontaneous tumors.
- To establish a tumor gene knockout (TuKO) protocol using the RCI-Oncogene system.
- To investigate the role of FGFR1 in mammary tumor metastasis.
Main Methods:
- Development of the RCI-Oncogene system for efficient in vivo gene delivery.
- Application of the RCI-Oncogene system for tumor gene knockout (TuKO).
- Utilizing mutant mouse hosts for targeted gene modification in tumors.
Main Results:
- The RCI-Oncogene system enables efficient manipulation of gene expression in spontaneous tumors.
- The TuKO approach using RCI-Oncogene demonstrated a critical role for FGFR1 in mammary tumor metastasis.
Conclusions:
- The RCI-Oncogene system is a versatile tool for tumor gene modification in vivo.
- The TuKO approach provides a robust method for studying gene function in spontaneous tumors.
- This technology can be adapted for various research questions in appropriate mouse models.
More Related Videos
Related Concept Videos
Retroviruses
Retrovirus Life Cycles
Cell Specific Gene Expression
Cell Specific Gene Expression
Mechanisms of Retrovirus-induced Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

